Business Wire

SEOUL-SEMICONDUCTOR

Share
Seoul Semiconductor Continuously Pursues patent infringement actions against Everlight products

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890) — On April 28, 2017, Seoul Semiconductor Europe GmbH (“Seoul”) filed a patent infringement claim in Germany at the District Court of Düsseldorf against Mouser Electronic Inc. (“Mouser), a global electronic components distributor, which it accused of selling Everlight LED products.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170524005266/en/

In its complaint, Seoul asserted that Everlight’s Mid-Power LED products are infringing Seoul’s patent rights. Seoul has sought a permanent injunction, damages, and recall and destruction of the allegedly infringing products.

The asserted patent serves to improve the light extraction performance of LED devices by enhancing internal-reflection efficiency, which has been widely used in mid-power and high-power LEDs.

This patent litigation is the second patent infringement litigation by Seoul or its affiliate affecting Everlight’s LED products. In March 2017, Seoul Semiconductor Co., Ltd. filed a patent infringement claim in Germany, accusing high-power LED products manufactured by Everlight as well as other LED manufacturers. These patent litigations underscore Seoul’s commitment to protecting its intellectual property rights against infringement, including products consisting of mid-power LEDs and high-power LEDs.

In addition to Seoul’s patent infringement actions, Everlight has been implicated in other patent infringement lawsuits as described below. Nam Ki-bum, Vice President of the Research Center at Seoul, said, “Several LED companies have grown rapidly in a short period of time despite a lack of valuable patent portfolios, which is like building a castle on quicksand. There is no underlying foundation for the company’s products. Seoul, however, has been investing 10% of its revenue in research and development for many years to develop innovative technology and strengthen our patent portfolio. To support a fair market that respects intellectual property rights, Seoul will continuously monitor and take action against alleged infringers in any countries where infringement occurs.”

* Reference [source: various media news articles]

Plaintiff   Defendant   Business Relation   Patented Technology   Courts   State   Link
Nichia   WOFI Leuchten   Everlight subsidiary   phosphor   Düsseldorf District Court, Germany   Nichia won the suit in the court of first instance and the court ruled for an injunction  

http://www.ledinside.com/news/2016/12
/nichia_clinches_two_legal_victories_ag
ainst_everlight_in_german_district_court
s

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122102.html

Nichia   REGO-Lighting   Used a white LED tube light product by Everlight subsidiary Zenar   phosphor   Düsseldorf District Court, Germany   On Dec. 5, 2016, the appeals court confirmed patent infringement and ruled in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_122101.html

http://www.ledinside.com/news/2016/12/
nichia_clinches_two_legal_victories_aga
inst_everlight_in_german_district_courts

Nichia   Everlight   Everlight   phosphor   Düsseldorf District Court, Germany   On Oct. 24, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_111701.html

http://www.ledinside.com/news/2016/11/
german_court_grants_nichia_preliminary
_injunctions_for_white_led_products_that
_infringed_patents

Nichia   Tachibana Eletech and E&E Japan   Distributor of blue LEDs manufactured by Everlight in Japan   LED chip   Tokyo District Court, Japan   On Oct. 14, 2016, the court issued an oder ruled for an infringement in favor of Nichia.  

http://www.nichia.co.jp/en/about_nichia/2016
/2016_102001.html

http://www.ledinside.com/press/2016/10/nich
ia_wins_patent_infringement_lawsuit_agains
t_tachibana_and_ee_japan_in_tokyo

Nichia   Mouser   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   On Oct. 7, 2016, the court granted a preliminary injunction.  

http://www.nichia.co.jp/en/about_nichia/2
016/2016_101301.html

http://www.ledinside.com/news/2016/10/g
erman_court_grants_preliminary_injunctio
n_against_mouser_based_on_nichia_yag
_patent

Nichia   Everlight   Everlight   LED Package   The U.S. District Court for the Eastern District of Texas   The Federal Circuit affirmed an infringement of Nichia’s patents.  

http://www.nichia.co.jp/en/about_nichia/20
17/2017_050901.html

http://www.ledinside.com/news/2017/5/nic
hia_wins_important_victory_in_federal_ci
rcuit_appeal

Nichia   EBV Elektronik GmbH & Co. KG and EBV Management GmbH (both “EBV“)   Distributor of Everlight products   phosphor   Düsseldorf District Court, Germany   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2017/2017_030802.html

http://www.ledinside.com/press/2017/3/nichia

_files_patent_infringement_lawsuit_against_

ebv_in_germany_regarding_white_led_

product_of_everlight

Nichia   Everlight Electronics (China) and Beijing Ducheng Yiguang Electronic Devices Selling Center   Everlight subsidiary   phosphor   Beijing Intellectual Property Court, China   Still in progress  

http://www.nichia.co.jp/en/about_nichia
/2016/2016_032401.html

http://www.ledinside.com/news/2016/3/
nichia_files_new_led_patent_infringem
ent_lawsuits_respectively_in_china_an
d_us

Seoul Semiconductor   Mouser   Distributor of Everlight products   High Power LED   Düsseldorf District Court, Germany   Still in progress  

http://www.ledinside.com/news/2017/4/se
oul_semiconductor_files_patent_infringe
ment_lawsuit_in_germany

Seoul Semiconductor   Mouser   Distributor of Everlight products   Mid Power LED   Düsseldorf District Court, Germany   On April 28, 2017, Seoul filed the lawsuit.    
           

About Seoul Semiconductor:

Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fifth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as Wicop – a simpler structured Package-Free LED which provides market leading color uniformity, cost savings at the fixture level with high lumen density and allows design flexibility; Acrich, the world's leading direct AC LED; Acrich MJT multi-junction technology; a proprietary family of high-voltage LEDs; NanoDriver Series – World’s Smallest 24W DC LED Drivers and nPola, a new LED product based on GaN-substrate technology that achieves over ten times the output of conventional LEDs.

For more information about Seoul Semiconductor, please visit http://www.seoulsemicon.com

# Trademarks: Wicop and Acrich are trademarks of Seoul Semiconductor Co., Ltd.

Contact:

Asia
Seoul Semiconductor Co., Ltd
Jake Jung, +82 070.4391.8270
Email: pr@seoulsemicon.com
or
Europe
Seoul Semiconductor Europe GmbH
Ariane Heim, +49 (0)89 450 3690-0
Email: press.eu@seoulsemicon.com
or
North America
Seoul Semiconductor Inc.
David Cox, +1 (919) 410-9856
Email: David.cox@seoulsemicon.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press release

Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of action and improvement of itch and sleep disturbance in patients with moderate-to-severe atopic dermatitis and prurigo nodularis1 Significant improvements in itch were observed as early as 48 hours after initial treatment and steadily increased through to Day 141 Nemolizumab is the first approved monoclonal antibody that specifically targets and inhibits the signalling of IL-31 – a neuroimmune cytokine that drives itch and other symptoms in atopic dermatitis and prurigo nodularis2-4 Nemolizumab is approved by multiple regulatory authorities around the world for the treatment of moderate-to-severe atopic dermatitis and prurigo nodularis, including in the U.S. and EU5,6 Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s r

Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press release

The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press release

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases. Collaboration supports Indonesian Government’s agenda to enhance diagnostic access and build national healthcare resilience. Multi-year agreement builds on GE HealthCare’s continued investment in local manufacturing, capability building and knowledge transfer to strengthen Indonesia’s healthcare ecosystem. GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully co

IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions16.12.2025 20:03:00 CET | Press release

The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most vital resource, with Saudi Arabia at the forefront. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216483490/en/ Investors, innovators, and global institutions gather in Saudi to outline how capital, collaboration, and governance can accelerate long term water sustainability (Photo: AETOSWire) Among the most consequential engagements were a series of meetings that brought together discussions powered by SWA, centred on shared challenges, knowledge exchange, and exploring opportunities within the global water ecosystem. Att

OAG Appoints ex-Skyscanner Executive Filip Filipov as New Chief Executive Officer16.12.2025 17:00:00 CET | Press release

OAG announces today the appointment of Filip Filipov, ex-Skyscanner executive, as new Chief Executive Officer. Filip Filipov currently serves as the company’s Chief Operating Officer and takes over from Phil Callow who has chosen to step down having completed thirteen transformational years at the helm of OAG to pursue his many other interests. Since joining in 2024, Filipovhas played a leading role in the company’s ambitious next phase of growth and ongoing acceleration. He will now lead OAG into a new era defined by advanced data products and AI-driven intelligence. Before joining OAG, Filipov held senior roles in travel technology and big-data consulting, including on Skyscanner’s executive team. Filip Filipov said: “It’s a privilege to step into this role and lead a company with such a strong heritage and reputation. I’m excited for what’s ahead and committed to serving our customers with the reliability, service, and innovation they depend on.” Chairman of OAG, Gehan Talwatte, com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye